Kevin McKernan

So there are hundreds of labs around the world doing those same types of experiments where they're taking spike proteins that have been sequenced and there's some differences and they want to characterize those differences, those variants of concern. Right. You may have heard of this, like there's Omicron, Delta, Alpha. Right, right, right.

So there are hundreds of labs around the world doing those same types of experiments where they're taking spike proteins that have been sequenced and there's some differences and they want to characterize those differences, those variants of concern. Right. You may have heard of this, like there's Omicron, Delta, Alpha. Right, right, right.

All of these differences, there is a lab somewhere out there cloning that difference, putting it into one of these vectors and putting them into mammalian cells to see, okay, is it worse or is it better? And that's how they could gauge whether Omicron was like less pathogenic than let's say alpha or delta.

All of these differences, there is a lab somewhere out there cloning that difference, putting it into one of these vectors and putting them into mammalian cells to see, okay, is it worse or is it better? And that's how they could gauge whether Omicron was like less pathogenic than let's say alpha or delta.

All of these differences, there is a lab somewhere out there cloning that difference, putting it into one of these vectors and putting them into mammalian cells to see, okay, is it worse or is it better? And that's how they could gauge whether Omicron was like less pathogenic than let's say alpha or delta.

So think of hundreds of labs around the world cloning different forms of the spike protein into vectors like this that have the capacity to shuttle between mammals and E. coli. that means they're like little zoonotic bombs, if you will, that if they get into the lab and they get out, they could spread at their own unknown rate. We don't know what the R0 is of that type of transmission.

So think of hundreds of labs around the world cloning different forms of the spike protein into vectors like this that have the capacity to shuttle between mammals and E. coli. that means they're like little zoonotic bombs, if you will, that if they get into the lab and they get out, they could spread at their own unknown rate. We don't know what the R0 is of that type of transmission.

So think of hundreds of labs around the world cloning different forms of the spike protein into vectors like this that have the capacity to shuttle between mammals and E. coli. that means they're like little zoonotic bombs, if you will, that if they get into the lab and they get out, they could spread at their own unknown rate. We don't know what the R0 is of that type of transmission.

It's not been followed. It's not been tracked very closely. But there is one case of it in the peer-reviewed literature already that it happened in Seattle. So that tells me if there's hundreds of other labs working on this, There could be leaks out there that we don't know about. So when I find something like this in a tumor biopsy that isn't identical to Pfizer, my head goes in that direction.

It's not been followed. It's not been tracked very closely. But there is one case of it in the peer-reviewed literature already that it happened in Seattle. So that tells me if there's hundreds of other labs working on this, There could be leaks out there that we don't know about. So when I find something like this in a tumor biopsy that isn't identical to Pfizer, my head goes in that direction.

It's not been followed. It's not been tracked very closely. But there is one case of it in the peer-reviewed literature already that it happened in Seattle. So that tells me if there's hundreds of other labs working on this, There could be leaks out there that we don't know about. So when I find something like this in a tumor biopsy that isn't identical to Pfizer, my head goes in that direction.

It's that, okay, this plasmid that we found it in is called PCDNA3. It is the most commonly used vector for people to study spike protein mutations. So some lab could have leaked this and gotten to this patient somehow. You can't pin it 100 percent of Pfizer because it's not the fingerprint Pfizer gave to the FDA unless Pfizer is playing with multiple plasmids, which their paper shows they are.

It's that, okay, this plasmid that we found it in is called PCDNA3. It is the most commonly used vector for people to study spike protein mutations. So some lab could have leaked this and gotten to this patient somehow. You can't pin it 100 percent of Pfizer because it's not the fingerprint Pfizer gave to the FDA unless Pfizer is playing with multiple plasmids, which their paper shows they are.

It's that, okay, this plasmid that we found it in is called PCDNA3. It is the most commonly used vector for people to study spike protein mutations. So some lab could have leaked this and gotten to this patient somehow. You can't pin it 100 percent of Pfizer because it's not the fingerprint Pfizer gave to the FDA unless Pfizer is playing with multiple plasmids, which their paper shows they are.

They just haven't disclosed what they are. So we're stuck with two hypotheses here that it could be something that is. contamination in Pfizer's lab that got into this guy's four shots. He gets it. He ends up with the tumor cancer later, or it could be this person knew somebody at a lab. It was a close proximity and got it from them.

They just haven't disclosed what they are. So we're stuck with two hypotheses here that it could be something that is. contamination in Pfizer's lab that got into this guy's four shots. He gets it. He ends up with the tumor cancer later, or it could be this person knew somebody at a lab. It was a close proximity and got it from them.

They just haven't disclosed what they are. So we're stuck with two hypotheses here that it could be something that is. contamination in Pfizer's lab that got into this guy's four shots. He gets it. He ends up with the tumor cancer later, or it could be this person knew somebody at a lab. It was a close proximity and got it from them.

And, and that this ended up replicating in his body and, and ends up with a, in his colon cancer in some way. So we don't know, but I think the important message I want to get across to people is that the current gain-of-function debate isn't talking about this. The gain-of-function debate is people like Barak making these full viruses.

And, and that this ended up replicating in his body and, and ends up with a, in his colon cancer in some way. So we don't know, but I think the important message I want to get across to people is that the current gain-of-function debate isn't talking about this. The gain-of-function debate is people like Barak making these full viruses.

And, and that this ended up replicating in his body and, and ends up with a, in his colon cancer in some way. So we don't know, but I think the important message I want to get across to people is that the current gain-of-function debate isn't talking about this. The gain-of-function debate is people like Barak making these full viruses.